tiprankstipranks
Advertisement
Advertisement

WAT Stock Latest News

Waters Shareholders Reelect Board and Ratify Auditor
Company AnnouncementsWaters Shareholders Reelect Board and Ratify Auditor
9d ago
8K
WAT
Waters price target raised to $350 from $330 at Deutsche Bank
PremiumThe Fly
Waters price target raised to $350 from $330 at Deutsche Bank
24d ago
WAT
Waters price target raised to $425 from $400 at Barclays
PremiumThe Fly
Waters price target raised to $425 from $400 at Barclays
24d ago
WAT
Waters price target raised to $387 from $362 at Baird
PremiumThe Fly
Waters price target raised to $387 from $362 at Baird
24d ago
WAT
Waters price target raised to $345 from $330 at JPMorgan
PremiumThe Fly
Waters price target raised to $345 from $330 at JPMorgan
24d ago
WAT
Waters price target raised to $385 from $345 at TD Cowen
PremiumThe FlyWaters price target raised to $385 from $345 at TD Cowen
24d ago
WAT
Waters price target raised to $375 from $330 at UBS
Premium
The Fly
Waters price target raised to $375 from $330 at UBS
24d ago
WAT
Daniel Brennan Lifts Waters Price Target to $385 but Maintains Hold on Balanced Risk‑Reward and BD Uncertainty
Premium
Ratings
Daniel Brennan Lifts Waters Price Target to $385 but Maintains Hold on Balanced Risk‑Reward and BD Uncertainty
25d ago
WAT
Equal-Weight Maintained on Waters as Integration Progresses; Price Target Reaffirmed at $350
PremiumRatings
Equal-Weight Maintained on Waters as Integration Progresses; Price Target Reaffirmed at $350
25d ago
WAT
Waters Corp Earnings Call Showcases Strong Start
PremiumCompany Announcements
Waters Corp Earnings Call Showcases Strong Start
26d ago
WAT
Early notable gainers among liquid option names on May 5th
PremiumThe Fly
Early notable gainers among liquid option names on May 5th
26d ago
DD
MU
Morning Movers: PayPal, Shopify drop following quarterly earnings reports
PremiumThe Fly
Morning Movers: PayPal, Shopify drop following quarterly earnings reports
26d ago
DD
FN
Analyst Reiterates Buy on Waters as Pharma Demand, BD Synergies and Earnings Outlook Drive Positive Risk-Reward
PremiumRatingsAnalyst Reiterates Buy on Waters as Pharma Demand, BD Synergies and Earnings Outlook Drive Positive Risk-Reward
26d ago
WAT
Waters raises FY26 EPS view to $14.40-$14.60 from $14.30-$14.50
Premium
The Fly
Waters raises FY26 EPS view to $14.40-$14.60 from $14.30-$14.50
26d ago
WAT
Waters reports Q1 adjusted EPS $2.70, consensus $2.31
Premium
The Fly
Waters reports Q1 adjusted EPS $2.70, consensus $2.31
26d ago
WAT
Waters sees Q2 adjusted EPS $2.95-$3.05, consensus $3.00
PremiumThe Fly
Waters sees Q2 adjusted EPS $2.95-$3.05, consensus $3.00
26d ago
WAT
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
27d ago
DD
IT
Is WAT a Buy, Before Earnings?
PremiumPre-Earnings
Is WAT a Buy, Before Earnings?
28d ago
WAT
Waters price target lowered to $330 from $370 at UBS
PremiumThe Fly
Waters price target lowered to $330 from $370 at UBS
2M ago
WAT
Waters announces FDA clearance of Onclarity HPV Self-Collection Kit
PremiumThe FlyWaters announces FDA clearance of Onclarity HPV Self-Collection Kit
2M ago
WAT
Waters upgraded to Outperform from In Line at Evercore ISI
Premium
The Fly
Waters upgraded to Outperform from In Line at Evercore ISI
2M ago
WAT
Waters reinstated with a Buy at Goldman Sachs
Premium
The Fly
Waters reinstated with a Buy at Goldman Sachs
2M ago
WAT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >